Table 2

Association between persistent hyperlactataemia and mortality*

SettingPopulationOverall mortality (%)Thresholds for lactate reductionRelative risk of deathSensitivitySpecificityPPVNPVMortality timeframe
Hospital admissions (East Africa)11 60 days to 12 years
with severe febrile illness (n=1906)
5.98Failure to fall by >40% and/or lactate >2.5 mmol/L at 8 h2.064%54.3%8.2%96%72 h
Hospital admissions (Uganda)10 <5 years with a diagnosis of pneumonia (n=75)17.33Failure to fall by >40% by 8 h2.853.8%75.8%31.8%88.7%In-hospital death or survival
PICU admissions (India)12 1 month to 12 years
with septic shock (n=148)
63.5Failure to fall >10% from baseline at 24 h2.578.7%
(68.8% to 86.2%)
72.2%
(58.1% to 83.1%)
83.1%
(73.4% to 89.9%)
66.1%
(52.5% to 77.5%)
In-hospital death or survival
PICU admissions (India)15 1 month to 17 years with septic shock (n=112)31.3Failure to fall >20% from baseline at 24 h12.192%63%84.5%78.6%60 days
  • *95% CIs provided (in brackets) where available in text or via author correspondence.

  • NPV, negative predictive value; PPV, positive predictive value.